350431 <common-name>3-chloro-1-[[4-[[3-chloro-2-(3,4-dimethoxyphenyl)-4-oxoazetidin-1-yl]amino]phthalazin-1-yl]amino]-4-(3,4-dimethoxyphenyl)azetidin-2-one</common-name> <description>3-chloro-1-[[4-[[3-chloro-2-(3,4-dimethoxyphenyl)-4-oxoazetidin-1-yl]amino]phthalazin-1-yl]amino]-4-(3,4-dimethoxyphenyl)azetidin-2-one is a chemical compound with the formula C30H28Cl2N6O6. With an average molecular weight of 639.50 g/mol, 3-chloro-1-[[4-[[3-chloro-2-(3,4-dimethoxyphenyl)-4-oxoazetidin-1-yl]amino]phthalazin-1-yl]amino]-4-(3,4-dimethoxyphenyl)azetidin-2-one is a heavy molecule.</description> <cas>139108-69-3</cas> <pubchem-id>6410680</pubchem-id> <chemical-formula>C30H28Cl2N6O6</chemical-formula> <weight>639.5</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T15:30:01Z</created-at> <updated-at type="dateTime">2026-08-31T15:30:01Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>COC1=C(C=C(C=C1)C2C(C(=O)N2NC3=NN=C(C4=CC=CC=C43)NN5C(C(C5=O)Cl)C6=CC(=C(C=C6)OC)OC)Cl)OC</moldb-smiles> <moldb-formula>C30H28Cl2N6O6</moldb-formula> <moldb-inchi>InChI=1S/C30H28Cl2N6O6/c1-41-19-11-9-15(13-21(19)43-3)25-23(31)29(39)37(25)35-27-17-7-5-6-8-18(17)28(34-33-27)36-38-26(24(32)30(38)40)16-10-12-20(42-2)22(14-16)44-4/h5-14,23-26H,1-4H3,(H,33,35)(H,34,36)</moldb-inchi> <moldb-inchikey>JUPOBBWHUYHXIF-UHFFFAOYSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">638.144738</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>4.9</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM346324</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>3-chloro-1-[[4-[[3-chloro-2-(3,4-dimethoxyphenyl)-4-oxoazetidin-1-yl]amino]phthalazin-1-yl]amino]-4-(3,4-dimethoxyphenyl)azetidin-2-one</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organoheterocyclic compounds</superklass> <klass>Lactams</klass> <subklass>Beta lactams</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0300736</sync-id> <structure-inchikey>JUPOBBWHUYHXIF-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>4000000000000000000000200800000000800008008000000000000100000400000000000000020000000000000002000000000000000000000000000000000000000000000000000000000000000000020000000000100081000000000000000000000000000000040000000100000000000000100000000000000000000100000000040000000800000000000000080080000000100000000000400000081000000000000000000040000080002000000000000000000000000000040000080000000040000000000000000000100000010000000000000000200000100000010000000000000000040000000000008000000008020080008000000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAsAAAAMQAAAIABBgBgAAAAAQMIACgAAAAD AgZAKAAAAAMEBkAoAAAAAwQGQGgAAAADAwEGQCgAAAADBAZAaAAAAAMDAQZA aAAAAAMDAQYAYAAAAAMBBgBgAAAAAwEGACgAAAADBAgAKAAAAAMCBwAoAAAA AwMHAGgAAAADAgEGQCgAAAADBAdAKAAAAAMDB0AoAAAAAwMGQCgAAAADBAZA KAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBBkBoAAAAAwMBBkBoAAAAAwMBBkAo AAAAAwQHAGgAAAADAgEHACgAAAADAwYAYAAAAAMBBgBgAAAAAwEGACgAAAAD BAgAKAAAAAMCEQAgAAAAAQZAKAAAAAMEBkBoAAAAAwMBBkAoAAAAAwQGQCgA AAADBAZAaAAAAAMDAQZAaAAAAAMDAQgAKAAAAAMCBgBgAAAAAQMIACgAAAAD AgYAYAAAAAEDEQAgAAAAAQgAKAAAAAMCBgBgAAAAAQMLAAEAAQIgAgNoDAME aAwEBWgMBQZoDAYHaAwFCAAICQAJCgAKCygCCgwgDA0ADQ4gDg9oDA8QaAwQ EWgMERJoDBITaAwTFGgMFBVoDBUWaAwWF2gMERggGBkAGRoAGhsAGxwAHB0o AhseABofAB8gaAwgIWgMISJoDCIjaAwjJGgMIiUgJSYAIScgJygACSkAAyog KisABwJoDAwIABcOaAwXEmgMHBkgJB9oDEIGAAAABgIHBgUEAwQJCgwIBg8Q ERIXDgYTFBUWFxIEGxwZGgYgISIjJB8XBAAAAAAAAAAW </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:48:24Z</structure-indexed-at> </compound>